The rising prevalence of unwanted pregnancies is boosting the global contraceptive drugs market. In a report, titled “Contraceptive Drugs Market Size, Share and Global Trend By Product Type (Oral, Injectable, Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs) and Geography Forecast till 2025” Fortune Business Insights identifies various factors enabling growth in the market. According to the report, the global contraceptive drugs market is anticipated to rise at 5.8% CAGR and reach a value of US$ 20,200.5 Mn by 2025 from US$ 13,097.7 Mn in 2017. Remarkably improving access to contraceptive pills around the world is a key factor propelling growth in this market.
The report covers:
- Global Contraceptive Drugs Market trends, with detailed analysis on consumer trends & manufacturer trends.
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors.
- Key areas of investments identifying market opportunities and challenges in forecast timeframe.
- Competitive analysis of the industry players along with the overview on strategic management.
- Comprehensive company profiles of the major industry players.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contraceptive-drugs-market-100063
Leading Players operating in the Contraceptive Drugs Market are:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:
- Bayer AG
- Pfizer Inc.
- Janssen Global Services, LLC
- Teva Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Mylan N.V.
- Allergan Plc
- Agile Therapeutics
- Piramal Enterprises Ltd.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Contraceptive Drugs Market Please visit:https://www.fortunebusinessinsights.com/industry-reports/contraceptive-drugs-market-100063
Rising Abortion Rates to Create Demand for Contraceptive Drugs
Under the Affordable Care Act (ACA) in the U.S., oral contraceptive pills are given free of cost to women in the U.S. Such regulations favor the growth of the contraceptive drugs market. Increasing government initiatives to reduce infant mortality due to early pregnancies will increase the demand for oral contraceptives.
Government Initiatives to Promote Use of Contraceptive Medicines
Geographically, North America held dominance in the global contraceptive drugs market owing to the presence of leading players in the region. This, accompanied with easy availability of contraceptive drugs, has catapulted North America to the fore of the global market. However, Asia Pacific is most likely to emerge as the fastest growing region.
This is owing to government initiatives adopted across emerging nations of this region. These initiatives are intended at promoting the use of contraceptive medicines as a convenient way of preventing unwanted pregnancy.
More Trending Topics from Fortune Business Insights:
The rising prevalence of unwanted pregnancies is boosting the global contraceptive drugs market.
In a report, titled “Contraceptive Drugs Market Size, Share and Global Trend By Product Type (Oral, Injectable, Patches), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel & NGOs) and Geography Forecast till 2025” Fortune Business Insights identifies various factors enabling growth in the market.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contraceptive-drugs-market-100063Leading Players operating in the Contraceptive Drugs Market are:Key players are involved in mergers and acquisition to strengthen their market position.
Some of the companies operating the industry are:Bayer AGPfizer Inc.Janssen Global Services, LLCTeva Pharmaceutical Industries Ltd.Merck & Co., Inc.Mylan N.V.Allergan PlcAgile TherapeuticsPiramal Enterprises Ltd.According to the report, the global contraceptive drugs market is anticipated to rise at 5.8% CAGR and reach a value of US$ 20,200.5 Mn by 2025 from US$ 13,097.7 Mn in 2017.
Remarkably improving access to contraceptive pills around the world is a key factor propelling growth in this market.Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/contraceptive-drugs-market-100063Rising Abortion Rates to Create Demand for Contraceptive DrugsUnder the Affordable Care Act (ACA) in the U.S., oral contraceptive pills are given free of cost to women in the U.S.
Increasing government initiatives to reduce infant mortality due to early pregnancies will increase the demand for oral contraceptives.
Contraceptive drugs not only help to control unwanted pregnancies but also reduce the number of abortion and complications associated with the procedure worldwide.
The global antiviral drugs market is set to gain impetus from the improvements in research collaborations of industry giants to develop state-of-the-art therapeutics.
Fortune Business Insights™ published this information in a recent study, titled, “Antiviral Drugs Market Size, Share & Industry Analysis, By Drug Class (Protease Inhibitors, Polymerase Inhibitors, Integrase Inhibitors, Combination Drugs, Reverse Transcriptase Inhibitors, and Others), By Disease Indication (Hepatitis, Human Immunodeficiency Virus (HIV), Influenza, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel) and Regional Forecast, 2019-2026.” The study further mentions that the antiviral drugs market size is projected to reach USD 44.2 billion by 2026, thereby exhibiting a CAGR of 3.2% during the forecast period.
We understand that this health crisis has brought an unprecedented impact on businesses across industries.
Rising support from governments and several companies can help in the fight against this highly contagious disease.
Overall, almost every sector is anticipated to be impacted by the pandemic.We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics.
The diagnosis rate of HIV is improving gradually owing to the refinement of surveillance by using biological and demographic data.
Visit here:https://onlinehealths.com/product-category/buy-soma-online/call us: +1(707) 510-0015 What is Soma medication suitable for?If you don’t know about Soma medication, let’s start.
When should Soma be taken?When you have any muscle cramps and you feel the need to take something for your treatment, Soma medicine will be best to treat you.
Is Soma A Good Muscle relaxer?When you see the Soma medicine, I can say that Soma online is good for muscle relaxers.
That has salts in it that block the pain sensation nerves that connect with the brain.
And then they bear problems like any side effect in the body.Do muscle relaxers affect the heart?Yes, muscle relaxer medicines affect your heart rate system.
Otherwise, you should avoid it.Does Soma make you sleepy?When you are consuming Soma medicine, the possibility of dizziness and drowsiness increases.
The UK "Economic and Retail Update - Q4 2018", report offers comprehensive insight and analysis of the UK economy and retail environment (including forecasts up to 2023).
It provides in-depth analysis of the following: the key issues regarding the UK economy (including CPI, unemployment rate and etc.
), and the key issues regarding the UK retail market (including online, offline and non-food markets).Get PDF Sample Copy of This Report at www.orbisresearch.com/contacts/request-sample/2415371Scope- The Budget announced a rise in both the National Living Wage and the non-taxable personal allowance threshold, which will provide consumers with additional funds in 2019.
However, the impact of a negative outcome of the Brexit negotiations would more than offset any potential gain.- The anticipated rise in food prices in 2019 and continued pressure on consumer funds will see food & groceries' share of the retail market increase 0.1ppts per year out to 2023.- Health & beauty continues to lead retail in terms of growth, with cosmetics, skincare and OTC medicines the sub-sectors of highest growth.
Non-specialists, such as the grocers, are looking to capitalise on this.- The continued physical expansion of the discounters, particularly Aldi and B, will turn negative offline growth in 2018 positive in 2019.
These retailers have indentified large-store locations vacated by retailers such as Homebase and Toys R Us as potential sites for future stores.Reasons to buy- Understand how announcements in the October 2018 Budget will impact retail, so you can prepare for changes in spend patterns as taxation and the personal allowance threshold changes- Learn about the interaction between unemployment and real wage growth, and how you will need to become more competitive with respect to recruitment- See how consumers' future sentiment is changing, allowing you to better prepare for upcoming macroeconomic uncertainty- Comprehend the importance of the online channel within different retail sectors, enabling you to create effective long-term strategies in this burgeoning market.Companies Mentioned:TescoAldiASDAASOSBBboohooCult BeautyDFSHome BargainsHomebaseLidllookfantasticMorrisonsSainsbury'sToys R UsMake an Inquiry before Buying@ www.orbisresearch.com/contacts/enquiry-before-buying/2415371Major Fundamentals of Table of Content:ECONOMIC UPDATEHeadlinesEconomic update: GDPEconomic update: inflationEconomic update: interest ratesEconomic update: unemploymentEconomic update: real wage growthEconomic update: savings ratioEconomic update: consumer confidenceEconomic update: house pricesEconomic update: house transaction changeRETAIL UPDATEAbout Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements.
